Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin d supplementation in patients with pulmonary tuberculosis'
BMC Infectious Diseases 2013, 13:22 doi:10.1186/1471-2334-13-22
Nawal Salahuddin, Farheen Ali, Zahra Hasan, Nisar Rao, Masooma Aqeel and Faisal Mahmood
Published: 19 January 2013
Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculosis (TB) could influence recovery.
Two hundred and fifty nine patients with pulmonary TB were randomized to receive either 600,000 IU of Intramuscular vitamin D3 or placebo for 2 doses. Assessments were performed at 4, 8 and 12 weeks. Early secreted and T cell activated 6 kDa (ESAT6) and Mycobacterium tuberculosis sonicate (MTBs) antigen induced whole blood stimulated IFN-g responses were measured at 0 and 12 weeks. Statistical comparisons between outcome variables at 0 and 12 weeks were performed using Student's t-test and Chi 2 tests.
After 12 weeks, the vitamin D supplemented arm demonstrated significantly
- greater mean weight gain (kg) + 3.75, (3.16 — 4.34)
versus + 2.61 (95% CI 1.99 — 3.23) p 0.009 and
- lesser residual disease by chest radiograph;
- number of zones involved 1.35 v/s 1.82 p 0.004 (95% CI 0.15, 0.79) and
- 50% or greater reduction in cavity size 106 (89.8%) v/s 111 (94.8%), p 0.035.
Vitamin D supplementation led to significant increase in MTBs-induced IFN-g secretion in patients with baseline 'Deficient' 25-hydroxyvitamin D serum levels (p 0.021).
Supplementation with high doses of vitamin D accelerated clinical, radiographic improvement in all TB patients and increased host immune activation in patients with baseline 'Deficient' serum vitamin D levels. These results suggest a therapeutic role for vitamin D in the treatment of TB.
Trial registration: ClinicalTrials.gov; No. NCT01130311; URL: clinicaltrials.gov
600,000 IU doses of vitamin D were given on day 0 and again on day 30 (from the PDF)
Reminder: TB sanitoriums, which gave direct sunlight access to TB patients, were found to be very userul a century ago.
- TB arrested by cod-liver oil (containing vitamin D) in 1848 3X better than other treatments at the time
CLICK HERE if registered (free) for updated analysis of the 1848 study
- All items in TB and vitamin D
Intervention AND TB in VitaminDWiki
Every TB patient benefited from 2 doses of 600,000 IU of vitamin D – RCT Jan 2013
- TB not treated by average daily 10,000 IU of vitamin D (previous RCTs disagree) – RCT Sept 2017
- Tuberculosis recovery speeded up by single 450,000 IU dose of vitamin D – RCT Jan 2017
- Tuberculosis treatment greatly helped by injection of 200,000 IU of vitamin D – RCT April 2016
- Tuberculosis -100 percent cure rate with 10,000 IU of vitamin D daily – RCT 2006
- Tuberculosis not treated by lots of vitamin D for 16 weeks – RCT Sept 2015
- Every TB patient benefited from 2 doses of 600,000 IU of vitamin D – RCT Jan 2013
- TB treatment helped with Vitamin D – RCT Sept 2012
- Probability of getting TB reduced 60 percent with just 800 IU of vitamin D – RCT Aug 2012
- Overview Tuberculosis and Vitamin D
- Evaluating the vitamin D evidence - Heaney Dec 2010
4886 visitors, last modified 12 Jun, 2021,This page is in the following categories (# of items in each category)Tuberculosis 110 Intervention 671